Improved Biosynthesis of Ethylene Glycol From Xylose in Engineered E. coli Utilizing Two‐Stage Dynamic Control
Biotechnology Journal · 2026-11 · 21 (11)
DOI: 10.1002/biot.70329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, online erschienen am 28.10.2026. Verfasst von Payel Sarkar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Duke University, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Escherichia coli, Xylose, Ethylene Glycol, Metabolic Engineering. Die Arbeit nennt 64 Literaturangaben.
Abstract (Originalsprache)
We engineered Escherichia coli for improved ethylene glycol (EG) biosynthesis using two‐stage dynamic metabolic control coupled with pathway optimization. An engineered Dahms pathway ( xylB, xylC, xylD, yqhD ) was induced upon phosphate depletion to enable EG biosynthesis during stationary phase. The performance of our initial strain, expressing a baseline pathway, was improved by the addition of “stoichiometric” valves enabling proteolytic degradation of xylose isomerase and soluble transhydrogenase, upon phosphate depletion. Reduction of these enzymes, which compete for substrates with EG biosynthesis, led to a 3‐fold increase in specific productivity. In contrast, enabling “regulatory” dynamic metabolic valves targeting enoyl‐ACP reductase and glucose‐6‐phosphate dehydrogenase, designed to enhance NADPH flux, did not improve production in this control. Following pathway optimization, regulatory strains exhibited enhanced production rates exceeding 0.5 g gCDW − 1 h − 1 , a 14‐fold improvement over the control, while stoichiometric valves conferred no benefit. Scale‐up in fed‐batch bioreactors achieved 140 g L − 1 EG in 70 h with a yield of 0.38 g g − 1 xylose (92% of theoretical), representing one of the highest reported titers in E. coli . These results demonstrate that optimal engineering strategies shift with pathway capacity. While elimination of competing fluxes benefits low‐flux systems, high‐flux pathways require enhanced cofactor regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Duke University, Durham, North Carolina, USA.
- Department of Chemistry, Duke University, Durham, North Carolina, USA.
ORCID-Profile: Michael D Lynch
Zitieren
APA
Sarkar, P., Li, S., Yano, U., Chen, J., & Lynch, M. D. (2026). Improved Biosynthesis of Ethylene Glycol From Xylose in Engineered E. coli Utilizing Two‐Stage Dynamic Control. Biotechnology Journal, 21(11). https://doi.org/10.1002/biot.70329
Vancouver
Sarkar P, Li S, Yano U, Chen J, Lynch MD. Improved Biosynthesis of Ethylene Glycol From Xylose in Engineered E. coli Utilizing Two‐Stage Dynamic Control. Biotechnology Journal. 2026;21(11). doi:10.1002/biot.70329
BibTeX
@article{Sarkar2026,
author = {Sarkar, Payel and Li, Shuai and Yano, Utsuki and Chen, Jiani and Lynch, Michael D},
title = {Improved Biosynthesis of Ethylene Glycol From Xylose in Engineered E. coli Utilizing Two‐Stage Dynamic Control},
journal = {Biotechnology Journal},
year = {2026},
volume = {21},
number = {11},
doi = {10.1002/biot.70329}
}
EUVIMED